论文部分内容阅读
目的探讨对充血性心力衰竭(心衰)合并心律失常患者应用厄贝沙坦、胺碘酮治疗疗效。方法随机将心衰伴室性心律失常患者70例分为实验A组、B组各35例。两组均进行常规治疗,B组同时应用胺碘酮,A组应用厄贝沙坦、胺碘酮。结果两组左室射血分数均较治疗前差异有统计学意义(P<0.05),实验A组左室射血分数较实验B组有明显上升(P<0.05)。实验A组心律失常控制有效率80.00%,高于实验B组(χ2=5.25,P<0.05)。结论厄贝沙坦、胺碘酮治疗充血性心力衰竭合并心律失常疗效明显,值得应用。
Objective To investigate the effect of irbesartan and amiodarone on patients with congestive heart failure (CHF) and arrhythmia. Methods 70 patients with heart failure and ventricular arrhythmia were randomly divided into experimental group A and group B, 35 cases each. Both groups were routinely treated with amiodarone in group B and irbesartan and amiodarone in group A. Results The left ventricular ejection fraction (LVEF) in both groups was significantly higher than that before treatment (P <0.05). The left ventricular ejection fraction in experimental group A was significantly higher than that in experimental group B (P <0.05). Experimental group A arrhythmia control efficiency 80.00%, higher than the experimental group B (χ2 = 5.25, P <0.05). Conclusion Irbesartan, amiodarone treatment of congestive heart failure with arrhythmia obvious effect, it is worth applying.